Subject: Huge News at the close makes this a GBC TOP PICK!

From: "GBC Financial" <[email-masked]>
Date: Thu, 25 Nov 2004 12:33:26 -0600

Medical Trends Breakthrough Stock Watch

November 23, 2004

Medical Breakthrough Alert

Company: Southwestern Medical Solutions, Inc.

Ticker Symbol: SWNM

Current Price: $.14

Short-Term Target: $.60

Exchange: OTC

Industry Rating: STRONG

Southwestern Medical Solutions, Inc.

“… safer, more accurate medical testing “

Southwestern Medical owns a revolutionary product.
LabGuard Accucheck System

This Leading-Edge Technology Addresses Problems Concerning Risks And Accuracy In The Multibillion-Dollar On-Site Testing/Screening Market.

News Just Out! Southwestern Medical to acquire significant interest in Glacier Medical, LLC

“ Glacier Medical's proprietary technology appears to offer the best-known solution to the universal problem of needle-stick injuries among healthcare workers. Nearly a million needle stick injuries are estimated annually in the USA resulting in tragic illnesses… this solution represents an exciting entry into the multibillion-dollar medical needle/syringe market for Southwestern Medical (full story)

Your Investment ? Here's the beauty of this company as an

investment:

Southwestern Medical stock (SWNM) is only trading at around .14 a share!

The Insight On LabGuard Accucheck
• Simultaneous detection of multiple drugs in under 5 minutes

• Integrated collection and testing device for every sample

• Sterile sample and reagent/fluid-free handling

• Room temperature storage

• Clear positive/negative results

• Non-Leak-Spill-proof container

Ask yourself : “ How of often does one of these small companies come along with a break-through medical solution?” What should this do to the stock price as the company gains exposure?

Click here to read the full profile

The Investment Opportunity

Southwestern Medical Solutions

(ticker: SWNM ) Southwestern Medical's technology directly addresses inefficiencies and unwarranted risks associated with procedures and devices now in use, and promises to catapult the Company into the role of a key supplier in this large market. At such a cheap price investors have the chance right now to get in very cheap and watch this company make progress. Yes there is risk with thinly traded micro stock but there is great upside reward potential as well.

Corporate Snapshot : SOUTHWESTERN MEDICAL

Technology-led Southwestern Medical Solutions, Inc. is a development-stage company targeted at the multibillion-dollar medical devices business. Through internal Research & Development, as well as the acquisition of proprietary technology developed by others, SWNM intends to provide the healthcare industry with significant advancements in medical supplies and equipment. These technological advancements will focus upon fulfilling the needs for higher safety, better ease-of-use, and much-needed economic efficiencies within the healthcare industry.

All material herein was prepared by Geneva Bancorp Inc. (GBC) based upon information believed to be reliable.   AThe information contained herein is not guaranteed by BGC to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BGC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on www.gbcfinancial.com or mentioned herein. BGC has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. BGC has been compensated Ten Thousand Dollars for this opinion. BGC may also buy and sell shares of this security prior to or after this opinion. BGC may sell its shares for less than the target price given in this opinion. BGC's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. BGC will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

GBC Financial · 525 Richmond Street West, Ste. 208 · Toronto, ON M5V 1V5